Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
ZebraEye logo — Artificial Intelligence (AI) medical technology company

ZebraEye

Artificial Intelligence (AI) medical technology company

Founded 2023 United States Palo Alto, United States 2 employees Grant Total: $340.00K AI

General Information

Company Name ZebraEye
Founded Year 2023
Location United States Palo Alto, United States
Employees 2
Industries AI
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with ZebraEye. To contact ZebraEye, visit zebraeye.ai.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does ZebraEye compare?

A PDF of ZebraEye and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting ZebraEye soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About ZebraEye

ZebraEye is a cutting-edge Artificial Intelligence (AI) medical technology company, founded in 2023 and headquartered in the United States. Setting its sights on transforming the way rare eye diseases are diagnosed, ZebraEye innovates through AI to deliver timely and precise medical insights that are essential for early intervention and patient care.

At the heart of ZebraEye’s offerings is the Rare Eye Pathology Screening System, a trailblazing AI-driven solution. This technology autonomously detects Fuchs Endothelial Corneal Dystrophy (FECD), a condition notoriously difficult to identify. By championing this approach, ZebraEye is aiming to redefine diagnostic protocols and improve patient outcomes significantly.

The company recently secured a $40.00K grant investment on 03 March 2025, underscoring the confidence investors have in its potential to revolutionize AI applications in healthcare. With its commitment to innovation and clinical impact, ZebraEye is poised to make a substantial imprint on the AI and medical technology landscapes.

Business keywords: Medical Technology, Rare Eye Pathology, AI Technology, Autonomous Detection, Fuchs Endothelial Corneal Dystrophy, Timely Diagnosis, Rare Eye-Threatening Diseases

Services & Products

Ophthalmic image analysis system using AI to assist physicians in diagnosing and treating rare eye pathologies.

Target Customers

Ophthalmologists optometrists healthcare institutions patients with rare eye diseases

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Grant $40.00K -
03 Mar 2025
Pre Seed Round $300.00K 3
Mukan Arginbayev, Evgeny Matveev +1
01 Dec 2023

ZebraEye Alternatives & Competitors

View All Alternatives
ZebraEye vs
Eyenuk, Inc.
Eyenuk, Inc. United States

Global artificial intelligence (AI) medical technology and services company

24 employees
AI, Health Care
ZebraEye vs
Find Solution Ai
Find Solution Ai China

Find Solution Artificial Intelligence Limited is principally engaged in research, develop and use of...

Series A
12 employees
AI, Analytics
ZebraEye vs
Medmain Inc.
Medmain Inc. Japan

To create a world where medical services can be accessed with technology anywhere, anytime

Series A
16 employees
AI, Analytics
View all alternatives

FAQ About ZebraEye

Artificial Intelligence (AI) medical technology company
ZebraEye was founded in 2023.
ZebraEye is headquartered in Palo Alto, United States.
ZebraEye operates in AI. Its work centres on Medical Technology, Rare Eye Pathology, AI Technology and Autonomous Detection. Its customers include Ophthalmologists, optometrists and healthcare institutions.
ZebraEye has approximately 2 employees.
ZebraEye has completed 2 funding rounds, raising a total of $340.00K. The latest funding stage is Grant.
ZebraEye offers: Ophthalmic image analysis system using AI to assist physicians in diagnosing and treating rare eye pathologies..
Top alternatives and competitors to ZebraEye include Eyenuk, Inc., Find Solution Ai, Medmain Inc., Infervision. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
ZebraEye and Eyenuk, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for ZebraEye, https://bouncewatch.com/company/zebraeye, updated 3 July 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout